ORATS-BlgPst-CELGBuyout
Jan
3
Data , Markets

CELG buyout by BMY: What did the options market know?

Celgene (CELG) is to be bought by Bristol-Myers Squibb (BMY) at a 54% premium to the closing...

Read Post

Featured Posts

We're here, if you need us.

Still curious how we can help you?




LET'S CHAT